When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Anemia of chronic disease

Last reviewed: 7 Apr 2025
Last updated: 11 Oct 2024

Summary

Definition

History and exam

Key diagnostic factors

  • systemic symptoms of underlying condition
  • absent history of bleeding
  • physical finding suggesting infection
  • physical finding suggesting neoplasm
  • physical finding suggesting autoimmune disorder
Full details

Other diagnostic factors

  • absent history of high alcohol intake
  • absent history of exposure to chemicals and radiation
  • absent history of drugs known to be associated with risk of anemia
  • absent history of poor nutrition
  • decreased exercise tolerance
  • shortness of breath with exercise
  • fatigue
  • pallor
Full details

Risk factors

  • autoimmune disorders
  • malignancy
  • acute or chronic infection
  • critical illness, major trauma, or major surgery with delayed recovery
  • chronic disease
Full details

Diagnostic tests

1st tests to order

  • Hb
  • WBC and differential
  • platelet count
  • mean corpuscular volume (MCV)
  • mean corpuscular hemoglobin concentration (MCHC)
  • peripheral blood smear
  • serum ferritin
  • serum iron
  • total iron-binding capacity
  • transferrin saturation
  • absolute reticulocyte count
  • serum creatinine
Full details

Tests to avoid

  • flow cytometry
Full details

Tests to consider

  • C-reactive protein (CRP)
  • erythrocyte sedimentation rate
  • serum B12
  • serum folate
  • thyroid function tests
  • LFTs
  • indirect and direct bilirubin
  • LDH
  • erythropoietin
  • hemoglobin electrophoresis
  • bone marrow biopsy
  • soluble transferrin receptor
  • ratio of soluble transferrin receptor to log ferritin
Full details

Treatment algorithm

ACUTE

mild to moderate anemia (hemoglobin [Hb] 8 to 11 g/dL)

severe (Hb <8 g/dL) or life-threatening (Hb <6.5 g/dL) anemia

Contributors

Authors

Marina Beltrami Moreira, MD

Assistant Professor

The Ohio State University Wexner Medical Center

The Ohio State University College of Medicine

Columbus

OH

Disclosures

MBM has a pending research grant from the Pfizer-NCCN grant program.

Acknowledgements

Dr Marina Beltrami Moreira would like to gratefully acknowledge Dr Eric Kraut, Dr Marium Husain, Dr Alice Ma, Dr Damon Houghton, Dr Marco Giovannini, Dr Pasquale Niscola, Dr Karen D. Serrano, Dr Robert D. Woodson, and Dr Kiranveer Kaur, previous contributors to this topic. EK, MH, AM, DH, MG, PN, KDS, RDW, and KK declare that they have no competing interests.

Peer reviewers

Sean R. Lynch, MD

Professor of Clinical Medicine

Eastern Virginia Medical School

Norfolk

VA

Disclosures

SRL declares that he has no competing interests.

Christopher Pechlaner, MD

Associate Professor of Medicine

Innsbruck Medical University

Innsbruck

Austria

Disclosures

CP declares that he has no competing interests.

Robert Chen, MD

Hematology/Oncology Fellow

Department of Medical Oncology

University of Colorado Health Sciences Center

Denver

CO

Disclosures

RC declares that he has no competing interests.

Brady Stein, MD

Associate Professor of Medicine

Northwestern University

Evanston

IL

Disclosures

BS declares that he has no competing interests.

References

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Key articles

KDIGO Anemia Work Group. KDIGO clinical practice guideline for anemia in chronic kidney disease. Kidney Int Suppl. 2012;2(4):279-335.Full text

Bohlius J, Bohlke K, Castelli R, et al. Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO/ASH clinical practice guideline update. J Clin Oncol. 2019 Apr 10;37(15):1336-51.Full text  Abstract

National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: hematopoietic growth factors [internet publication].Full text

Aapro M, Beguin Y, Bokemeyer C, et al. Management of anaemia and iron deficiency in patients with cancer: ESMO clinical practice guidelines. Ann Oncol. 2018 Oct 1;29(suppl 4):iv271.

Reference articles

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
  • Differentials

    • Iron deficiency anemia
    • Iron deficiency anemia coexisting with ACD
    • Anemia associated with chronic renal disease (erythropoietin deficiency)
    More Differentials
  • Guidelines

    • NCCN clinical practice guidelines in oncology: hematopoietic growth factors
    • Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO/ASH clinical practice guideline update
    More Guidelines
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer